secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001193125-24-143419
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics cuts workforce by up to 87 employees, CTO departing in restructuring
--------------------------------------------------------------------------------

- Board approved reduction of up to 87 employees, ~80 effective May 21 and ~7 effective June 20, 2024.
- John E. Bishop (CTO) position eliminated; separation agreement to provide severance under employment agreement.
- Retention payments approved: CEO Maria Palasis receives $375,000 and CFO Jason Cavalier receives $266,666, payable in three installments through May 1, 2025.
- Company currently unable to estimate total costs associated with the workforce reduction; will file amendment later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524143419/0001193125-24-143419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524143419/d612188d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-143419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer